278 related articles for article (PubMed ID: 23855502)
1. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
Wan W; Chen H; Li Y
Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
[TBL] [Abstract][Full Text] [Related]
2. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
3. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
Wan W; Cao L; Liu L; Zhang C; Kalionis B; Tai X; Li Y; Xia S
J Neurochem; 2015 Jul; 134(2):382-93. PubMed ID: 25866188
[TBL] [Abstract][Full Text] [Related]
4. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; Rozemuller AJ; van Horssen J; de Vries HE
Antioxid Redox Signal; 2011 Sep; 15(5):1167-78. PubMed ID: 21294650
[TBL] [Abstract][Full Text] [Related]
5. EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.
Wan WB; Cao L; Liu LM; Kalionis B; Chen C; Tai XT; Li YM; Xia SJ
PLoS One; 2014; 9(11):e113126. PubMed ID: 25426944
[TBL] [Abstract][Full Text] [Related]
6. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
7. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
8. Aβ
Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
[TBL] [Abstract][Full Text] [Related]
9. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
[TBL] [Abstract][Full Text] [Related]
10. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
[TBL] [Abstract][Full Text] [Related]
12. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
Hanafy AS; Lamprecht A; Dietrich D
Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.
Song J; Choi SM; Whitcomb DJ; Kim BC
Cell Death Dis; 2017 Oct; 8(10):e3102. PubMed ID: 29022894
[TBL] [Abstract][Full Text] [Related]
14. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
15. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia.
Yan FL; Zheng Y; Zhao FD
Acta Neuropathol; 2008 Nov; 116(5):529-35. PubMed ID: 18830615
[TBL] [Abstract][Full Text] [Related]
16. Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells.
Askarova S; Yang X; Sheng W; Sun GY; Lee JC
Neuroscience; 2011 Dec; 199():375-85. PubMed ID: 21978883
[TBL] [Abstract][Full Text] [Related]
17. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
[TBL] [Abstract][Full Text] [Related]
18. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
19. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
[TBL] [Abstract][Full Text] [Related]
20. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.
Deane R; Du Yan S; Submamaryan RK; LaRue B; Jovanovic S; Hogg E; Welch D; Manness L; Lin C; Yu J; Zhu H; Ghiso J; Frangione B; Stern A; Schmidt AM; Armstrong DL; Arnold B; Liliensiek B; Nawroth P; Hofman F; Kindy M; Stern D; Zlokovic B
Nat Med; 2003 Jul; 9(7):907-13. PubMed ID: 12808450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
